In this case the taxpayer, a doctorsâ office, displayed various pieces of art in its offices, claimed depreciation on said artwork, which the IRS disallowed. At trial the IRS argued that the works of art did not have a useful life, based on Revenue Ruling 68-232.
A reduction in HAPU incidence by just 1 percentage point (3.5% to 2.5%) results in potential savings of $1,305,000 per year. Calculate your own potential savings below.
For the patients at low risk for stroke (0.72% per year with warfarin), low-dose dabigatran was more cost-effective than high-dose dabigatran and cost $40 355 per QALY compared with warfarin. For patients at high risk for stroke (2.35% per year with warfarin), high-dose dabigatran was more cost-effective and cost $39 680 per QALY compared with warfarin.